FDA Authorizes Automated Insulin Dosing App
Source: JDRF.org The U.S. Food and Drug Administration (FDA) has authorized the Tidepool Loop, an automated insulin dosing app intended for the management of type 1 diabetes (T1D). The Loop is essentially, an algorithm that can eventually be used to work with commercially available insulin pumps and continuous glucose monitors (CGMs). The goal of the […]